X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Novartis with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs LUPIN LTD - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS LUPIN LTD NOVARTIS/
LUPIN LTD
 
P/E (TTM) x 265.8 133.6 198.9% View Chart
P/BV x 22.6 2.5 911.3% View Chart
Dividend Yield % 1.6 1.0 159.7%  

Financials

 NOVARTIS   LUPIN LTD
EQUITY SHARE DATA
    NOVARTIS
Mar-17
LUPIN LTD
Mar-17
NOVARTIS/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs8551,750 48.9%   
Low Rs6661,384 48.1%   
Sales per share (Unadj.) Rs219.0387.4 56.5%  
Earnings per share (Unadj.) Rs19.156.6 33.7%  
Cash flow per share (Unadj.) Rs20.376.8 26.4%  
Dividends per share (Unadj.) Rs10.007.50 133.3%  
Dividend yield (eoy) %1.30.5 274.8%  
Book value per share (Unadj.) Rs307.0298.9 102.7%  
Shares outstanding (eoy) m29.96451.58 6.6%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x3.54.0 85.8%   
Avg P/E ratio x39.827.7 143.9%  
P/CF ratio (eoy) x37.520.4 183.7%  
Price / Book Value ratio x2.55.2 47.3%  
Dividend payout %52.413.2 395.4%   
Avg Mkt Cap Rs m22,779707,513 3.2%   
No. of employees `0000.716.8 4.0%   
Total wages/salary Rs m1,39328,495 4.9%   
Avg. sales/employee Rs Th9,736.210,418.3 93.5%   
Avg. wages/employee Rs Th2,066.81,697.0 121.8%   
Avg. net profit/employee Rs Th849.01,523.0 55.7%   
INCOME DATA
Net Sales Rs m6,562174,943 3.8%  
Other income Rs m7021,065 65.9%   
Total revenues Rs m7,264176,008 4.1%   
Gross profit Rs m25944,931 0.6%  
Depreciation Rs m369,122 0.4%   
Interest Rs m71,525 0.5%   
Profit before tax Rs m91735,349 2.6%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3459,785 3.5%   
Profit after tax Rs m57225,575 2.2%  
Gross profit margin %3.925.7 15.4%  
Effective tax rate %37.627.7 135.9%   
Net profit margin %8.714.6 59.6%  
BALANCE SHEET DATA
Current assets Rs m9,731119,542 8.1%   
Current liabilities Rs m1,83061,206 3.0%   
Net working cap to sales %120.433.3 361.1%  
Current ratio x5.32.0 272.2%  
Inventory Days Days4976 64.1%  
Debtors Days Days2590 28.0%  
Net fixed assets Rs m57131,660 0.0%   
Share capital Rs m141903 15.6%   
"Free" reserves Rs m9,056134,073 6.8%   
Net worth Rs m9,196134,976 6.8%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m11,499266,073 4.3%  
Interest coverage x128.424.2 531.1%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.60.7 86.8%   
Return on assets %5.010.2 49.5%  
Return on equity %6.218.9 32.8%  
Return on capital %10.119.3 52.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12981,885 0.2%   
Fx outflow Rs m1,73421,506 8.1%   
Net fx Rs m-1,60560,378 -2.7%   
CASH FLOW
From Operations Rs m-38041,148 -0.9%  
From Investments Rs m4,208-25,287 -16.6%  
From Financial Activity Rs m-3,3184,332 -76.6%  
Net Cashflow Rs m51020,193 2.5%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 75.0 0.2 37,500.0%  
Indian inst/Mut Fund % 2.0 11.3 17.7%  
FIIs % 1.6 31.9 5.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 10.1 212.9%  
Shareholders   41,647 98,259 42.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   J.B.CHEMICALS  SUVEN LIFE  CIPLA  CADILA HEALTHCARE  VENUS REMEDIES  

Compare NOVARTIS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 300 Points; Capital Goods Stocks Down 3%(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a negative note.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


May 18, 2018 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - VENUS REMEDIES COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS